The effect of blood-derived products on bone healing after surgery : A randomized clinical trial
- Conditions
- Health Condition 1: - Health Condition 2: M268- Other dentofacial anomaliesHealth Condition 3: K046- Periapical abscess with sinus
- Registration Number
- CTRI/2023/10/058270
- Lead Sponsor
- Supriya Choudhary
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
All patients within 18–40 years of age.
Single rooted, anterior teeth.
Teeth with peri apical radiolucency indicated for surgery.
Patients who are not on any medication affecting periapical healing. (corticosteroids, chemotherapeutic agents, non ?steroidal anti ? inflammatory drugs (NSAIDs), antibiotics, anticoagulants and drugs which reduce osteoclastic activity).
Patients who did not give their consent for participating in the study.
Patients having insufficient motivation to report back for follow up visits.
Patients with any systemic diseases like diabetes mellitus, hypertension, hepatitis, Human immunodeficiency virus, bone disorders, auto ?immune disorders.
Surgical retreatment cases.
Patients with malignant tumors or undergoing chemotherapy/ radiotherapy.
Pregnant females.
Patients with periodontally compromised teeth.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Surface area reductionTimepoint: 0,1,3,6 months
- Secondary Outcome Measures
Name Time Method Peak systolic velocityTimepoint: 0,1,3,6 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.